Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years
24/7 Wall St
Mon, 06/8/15 - 09:58 pm
Tags:
autoimmune disease, AbbVie, JNJ, Eli Lilly, Merck, Bristol-Myers Squibb, Pfizer
New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels
24/7 Wall St
Sun, 06/7/15 - 10:57 am
Tags:
FDA, advisory panels, Regeneron, AbbVie, Amgen, Repatha, alirocumab, PCSK9 inhibitors
Top-Performing Biotech and Drug Stocks During ASCO '15
TheStreet.com
Fri, 06/5/15 - 07:13 pm
Tags:
ASCO, Ignyta, Immunogen, Puma Biotechnology, AbbVie, Roche, Bristol-Myers Squibb, Seattle Genetics, Juno Therapeutics
Halozyme adds AbbVie to its roster of Big Pharma R&D collaborators
Fierce Biotech
Thu, 06/4/15 - 11:37 am
Tags:
Halozyme, AbbVie, R&D
Return of the Scarlet Letter? AbbVie Petitions FDA to Require Biosimilar Labeling to Include Disclaimers and a Description of Data Differences
Fierce Pharma Marketing
Wed, 06/3/15 - 07:40 pm
Tags:
FDA, biosimilars, AbbVie
The 4 Overlooked Winners of ASCO
24/7 Wall St
Tue, 06/2/15 - 09:12 am
Tags:
ASCO, Bristol-Myers Squibb, AbbVie, Aveo Pharmaceuticals, Ignyta
AbbVie Completes Acquisition of Pharmacyclics
Yahoo
Tue, 05/26/15 - 09:43 am
Tags:
AbbVie, Pharmacyclics, M&A
Who are Gilead Sciences' (GILD) main competitors?
Investopedia
Fri, 05/22/15 - 10:56 am
Tags:
Gilead Sciences, GSK, Pfizer, AbbVie, Merck, Bristol-Myers Squibb
Abbvie specifies breakdown of $21 billion Pharmacyclics deal
Yahoo/AP
Thu, 05/21/15 - 12:43 pm
Tags:
AbbVie, Pharmacyclics, M&A
AbbVie, other pharma companies dominate list of 'most meaningful' places to work in US
BioPharma Dive
Thu, 05/21/15 - 12:40 pm
Tags:
AbbVie, Becton Dickinson, Celgene, Medtronic
The top 10 advertisers in Big Pharma
Fierce Pharma Marketing
Mon, 05/18/15 - 11:27 am
Tags:
Pfizer, AbbVie, AstraZeneca, Eli Lilly, JNJ, Actavis, Merck, Bristol-Myers Squibb, Dainippon Sumitomo, Amgen, drug ads
AbbVie nabs FDA's orphan drug tag for Humira in HS
Fierce Pharma
Sun, 05/17/15 - 01:46 pm
Tags:
AbbVie, FDA, Humira, orphan drugs, hidradenitis suppurativa
AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc.
Yahoo
Sat, 05/16/15 - 02:10 pm
Tags:
AbbVie, Pharmacyclics, M&A
Galapagos inflates IPO again as AbbVie, J&J jockey for position
Fierce Biotech
Thu, 05/14/15 - 11:02 am
Tags:
Galapagos, IPOs, AbbVie, JNJ
Bristol, AbbVie drug extends multiple myeloma remission-study
Yahoo/Reuters
Thu, 05/14/15 - 09:56 am
Tags:
Bristol-Myers Squibb, AbbVie, Multiple Myeloma, elotuzumab
Pharmacyclics-AbbVie Merger Has Many Moving Parts
Seeking Alpha
Wed, 05/13/15 - 11:21 am
Tags:
AbbVie, Pharmacyclics, M&A
AbbVie, Roche nab FDA breakthrough designation for top leukemia prospect
BioPharma Dive
Fri, 05/8/15 - 11:01 am
Tags:
AbbVie, Roche, FDA, CLL, chronic lymphocytic leukemia, venetoclax
AbbVie leukemia drug gets breakthrough status
Medical Marketing and Media
Wed, 05/6/15 - 06:59 pm
Tags:
AbbVie, CLL, chronic lymphocytic leukemia, venetoclax
The Q1 drug launch scorecard, starring Sanofi, Lilly, Pfizer, Gilead, Merck and more
Fierce Pharma Marketing
Mon, 05/4/15 - 04:43 pm
Tags:
earnings, Sanofi, Eli Lilly, Pfizer, Gilead Sciences, Merck, AbbVie
AbbVie Again Extends Exchange Offer to Acquire Pharmacyclics, Inc.
Marketwatch
Sat, 05/2/15 - 01:14 pm
Tags:
AbbVie, Pharmacyclics, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.